| ||
Ligand Pharma slips as analyst cuts rating Businessweek NEW YORK (AP) — Shares of Ligand Pharmaceuticals Inc. fell Friday after an analyst downgraded the company, citing the run-up in its stock price and setbacks for two drug candidates. THE SPARK: Cantor Fitzgerald analyst Irina Rivkind downgraded the ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment